RecruitingNCT07659418
PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
Sponsor
CorEvitas
Enrollment
2,500 participants
Start Date
Aug 21, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The design is a prospective, observational (non-interventional) registry for adolescent and adult subjects with NSV under the care of a dermatology provider.
Eligibility
Min Age: 12 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with vitiligo. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07659418
Related Trials
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT0753301935 locations
A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo
NCT07682506
An Observational Study of Patients With Dermatologic Disease
NCT07748169
Study of D-2570 in Subjects With Non-Segmental Vitiligo
NCT076258911 location
The Gut and Skin Microbiome in Vitiligo Disease Progression
NCT035773271 location